Breaking News
Sort by:
Top Post
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
Targovax Announces That the FDA Has Granted Authorization to Initiate Clinical Trials With the Enhanced TG01 RAS Vaccine in the USA
Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid […]
Börje Haraldsson Appointed Ceo of Oncorena AB
Oncorena AB, which is developing a new and potentially groundbreaking treatment for patients with advanced […]
DTx Leader Sidekick Enters Strategic Collaboration With Lilly to Support Patients With Breast Cancer
International digital therapeutics (DTx) innovator, Sidekick Health (www.sidekickhealth.com), today announces an integrated digital therapeutics solution in conjunction […]
Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology in Cancer Immunotherapy
Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS (Emercell) announced today the recent exercise of […]
Novartis Receives GB Licence for Scemblix®▼ (Asciminib), the First STAMP Inhibitor for Patients With Chronic Myeloid Leukaemia
Novartis UK has announced that Scemblix® (asciminib) has been granted Marketing Authorisation in Great Britain by […]
Nonagen Bioscience Announces CE Mark for Oncuria® Bladder Cancer Diagnostic
Nonagen Bioscience, a cancer diagnostics company, today announced CE marking for its Oncuria® immunoassay for […]
Roche Launches Human Papillomavirus (HPV) Self-sampling Solution, Expanding Cervical Cancer Screening Options
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of a human papillomavirus (HPV) […]
Center for Breakthrough Medicines Accelerates Plans to Build the Largest Cell Therapy Manufacturing Operation in the World
The Center for Breakthrough Medicines (CBM) in partnership with the Discovery Labs announced today the […]
High Street Pharmacies Spot Cancers In New NHS Early Diagnosis Drive
Staff in high street pharmacies will be funded to spot signs of cancer as part […]
Spirea Raises £2.4M ($3M) to Develop Antibody Drug Conjugates in Cancer
Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more